HRP20080245T3 - Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication - Google Patents

Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication

Info

Publication number
HRP20080245T3
HRP20080245T3 HR20080245T HRP20080245T HRP20080245T3 HR P20080245 T3 HRP20080245 T3 HR P20080245T3 HR 20080245 T HR20080245 T HR 20080245T HR P20080245 T HRP20080245 T HR P20080245T HR P20080245 T3 HRP20080245 T3 HR P20080245T3
Authority
HR
Croatia
Prior art keywords
6alkyl
6alkyloxy
mono
substituted
ar1c1
Prior art date
Application number
HR20080245T
Other languages
English (en)
Croatian (hr)
Inventor
Bonfanti Jean-Fran�ois
Jozef Koenraad
Michel J�r�me
Muller Philippe
Marc Fr�d�ric
Meyer Christophe
Edmond Willebrords Rudy
Valerius Tom
Maria Philip
Original Assignee
Tibotec Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34704695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20080245(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharmaceuticals Ltd. filed Critical Tibotec Pharmaceuticals Ltd.
Publication of HRP20080245T3 publication Critical patent/HRP20080245T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20080245T 2003-12-18 2008-06-03 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication HRP20080245T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03104810 2003-12-18
US56718204P 2004-04-30 2004-04-30
EP04105312 2004-10-26
PCT/EP2004/053620 WO2005058871A1 (en) 2003-12-18 2004-12-20 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication

Publications (1)

Publication Number Publication Date
HRP20080245T3 true HRP20080245T3 (en) 2008-07-31

Family

ID=34704695

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080245T HRP20080245T3 (en) 2003-12-18 2008-06-03 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication

Country Status (33)

Country Link
US (2) US7449463B2 (de)
EP (1) EP1697345B1 (de)
JP (1) JP4951348B2 (de)
KR (1) KR100967406B1 (de)
CN (2) CN101412709B (de)
AP (1) AP2150A (de)
AR (1) AR046959A1 (de)
AT (1) ATE388950T1 (de)
AU (1) AU2004298460B2 (de)
BR (1) BRPI0417268B8 (de)
CA (1) CA2548668C (de)
CY (1) CY1108142T1 (de)
DE (1) DE602004012448T2 (de)
DK (1) DK1697345T3 (de)
EA (1) EA009876B1 (de)
EG (1) EG25799A (de)
ES (1) ES2303653T3 (de)
HK (1) HK1130799A1 (de)
HR (1) HRP20080245T3 (de)
IL (1) IL175910A (de)
ME (1) ME01042B (de)
MX (1) MXPA06007112A (de)
MY (1) MY143573A (de)
NO (1) NO339314B1 (de)
NZ (1) NZ547479A (de)
PL (1) PL1697345T3 (de)
PT (1) PT1697345E (de)
RS (1) RS50584B (de)
SI (1) SI1697345T1 (de)
TW (1) TWI351401B (de)
UA (1) UA84718C2 (de)
WO (1) WO2005058871A1 (de)
ZA (1) ZA200605894B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
TWI370820B (en) 2005-04-27 2012-08-21 Takeda Pharmaceutical Fused heterocyclic compounds
US8034835B2 (en) * 2005-06-20 2011-10-11 Tibotec Pharmaceuticals Ltd. 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs
AU2006260970B2 (en) * 2005-06-20 2012-07-05 Janssen Sciences Ireland Uc Heterocyclylaminoalkyl substituted benzimidazoles
US20120148678A1 (en) 2010-12-08 2012-06-14 Advanced Technologies And Regenerative Medicine, Llc. Sustained release of poorly water soluble active compounds
TWI650321B (zh) 2011-10-14 2019-02-11 美商安比特生物科學公司 雜環化合物及其使用方法
UA119050C2 (uk) * 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
CN109562160B (zh) * 2016-05-10 2022-07-29 乔治亚州立大学研究基金会股份有限公司 用于治疗rsv的双环稠合的吡唑衍生物
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW202244048A (zh) 2017-03-20 2022-11-16 美商佛瑪治療公司 作為丙酮酸激酶(pkr)活化劑之吡咯并吡咯組成物
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗rsv活性之吡唑并嘧啶
US11491157B2 (en) 2018-01-31 2022-11-08 Janssen Sciences Ireland Unlimited Company Co Cork, IE Cycloalkyl substituted pyrazolopyrimidines having activity against RSV
WO2019206828A1 (en) 2018-04-23 2019-10-31 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against rsv
CN113226356A (zh) 2018-09-19 2021-08-06 福马治疗股份有限公司 活化丙酮酸激酶r
EP3853206B1 (de) 2018-09-19 2024-04-10 Novo Nordisk Health Care AG Behandlung von sichelzellanämie mit einer pyruvatkinase-r-aktivierenden verbindung
GB201820751D0 (en) * 2018-12-19 2019-01-30 Bp Oil Int Methods for preparing intermediates
CA3147397A1 (en) 2019-07-22 2021-01-28 Lupin Limited Macrocyclic compounds as sting agonists and methods and uses thereof
JP7329239B2 (ja) 2019-09-20 2023-08-18 株式会社タマディック フライトシミュレーター
EP4384168A1 (de) * 2021-08-13 2024-06-19 Georgia State University Research Foundation, Inc. Bicyclische kondensierte pyrazolderivate zur behandlung von atemwegsinfektionen einschliesslich rsv

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1418175A1 (de) * 1999-06-28 2004-05-12 Janssen Pharmaceutica N.V. Replikationsinhibitoren des respiratorischen Synzytialvirus
PT1196410E (pt) * 1999-06-28 2004-07-30 Janssen Pharmaceutica Nv Inibidores da replicacao de virus sincicial respiratorio
AU778218B2 (en) * 1999-06-28 2004-11-25 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
AU2004298457B2 (en) * 2003-12-18 2010-05-27 Tibotec Pharmaceuticals Ltd. Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication

Also Published As

Publication number Publication date
EA200601178A1 (ru) 2006-10-27
CN101412709A (zh) 2009-04-22
ME01042B (me) 2012-10-20
WO2005058871A1 (en) 2005-06-30
JP4951348B2 (ja) 2012-06-13
MXPA06007112A (es) 2006-08-23
DE602004012448T2 (de) 2009-03-26
JP2007514720A (ja) 2007-06-07
CN101412709B (zh) 2015-03-25
DE602004012448D1 (de) 2008-04-24
DK1697345T3 (da) 2008-06-23
EG25799A (en) 2012-08-06
CY1108142T1 (el) 2014-02-12
IL175910A (en) 2013-08-29
CA2548668C (en) 2011-09-20
BRPI0417268A (pt) 2007-03-13
CA2548668A1 (en) 2005-06-30
KR20070015507A (ko) 2007-02-05
US20080280881A1 (en) 2008-11-13
PL1697345T3 (pl) 2008-08-29
AP2150A (en) 2010-09-04
AU2004298460B2 (en) 2009-03-19
PT1697345E (pt) 2008-06-12
RS50584B (sr) 2010-05-07
AP2006003640A0 (en) 2006-06-30
US20070043022A1 (en) 2007-02-22
TWI351401B (en) 2011-11-01
BRPI0417268B8 (pt) 2021-05-25
AU2004298460A1 (en) 2005-06-30
SI1697345T1 (sl) 2008-08-31
NZ547479A (en) 2009-03-31
KR100967406B1 (ko) 2010-07-01
HK1130799A1 (en) 2010-01-08
ZA200605894B (en) 2008-01-08
UA84718C2 (ru) 2008-11-25
CN1894237A (zh) 2007-01-10
EA009876B1 (ru) 2008-04-28
NO339314B1 (no) 2016-11-28
EP1697345A1 (de) 2006-09-06
NO20063322L (no) 2006-09-18
US7449463B2 (en) 2008-11-11
ATE388950T1 (de) 2008-03-15
US8883837B2 (en) 2014-11-11
TW200531972A (en) 2005-10-01
MY143573A (en) 2011-05-31
ES2303653T3 (es) 2008-08-16
BRPI0417268B1 (pt) 2018-10-23
IL175910A0 (en) 2006-10-05
EP1697345B1 (de) 2008-03-12
AR046959A1 (es) 2006-01-04

Similar Documents

Publication Publication Date Title
HRP20080245T3 (en) Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
CA2548654A1 (en) Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
HRP20191268T1 (hr) Derivati tieno[2,3-c]pirol-4-ona kao inhibitori erk
HRP20211728T1 (hr) Rsv antivirusni pirazolo- i triazolo-pirimidinski spojevi
AR053195A1 (es) Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo
MA54755A (fr) Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4
NO20051051L (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler
HRP20201094T1 (hr) IMIDAZO[1,2-a]PIRIDINI, NAMIJENJENI LIJEČENJU ILI SPRJEČAVANJU HIPERURIKEMIJE ILI GIHTA
NO20091394L (no) Pyridin-4-yl-derivater som immunmodulerende midler
NO20091409L (no) Pyridin-3-yl-derivater som immunmodulerende midler
RS54718B1 (en) 1,2,4-THIAZOLIDIN-3-DERIVATIVES AND THEIR USE IN CANCER TREATMENT
MX2016005324A (es) Composiciones pesticidas y metodos relacionados.
NO20075082L (no) Pyridin-3-karboksamidderivater som CB1-inversagonister
HRP20181036T1 (hr) 2,6-supstituirani derivati purina i njihova upotreba u liječenju proliferativnih poremećaja
RU2013149174A (ru) Новое имидазооксазиновое соединение или его соль
NZ701959A (en) Novel β-lactamase inhibitor and method for producing same
NO20084129L (no) Pyridin(3,4-B)Pyrazinoner
RS53191B (en) HINOLINE DERIVATIVES AS ANTI-BACTERIAL AGENTS
AR100171A1 (es) Compuestos de diaminotriazina y su uso como herbicida
NO20076424L (no) N-koblete heterocykliske antagonister av P2Y1 reseptoren nyttige for behandling av tromboseforstyrrelser
DK1913004T3 (da) 8-methoxy-9h-isothiazolo[5,4-b]quinolin-3,4-dioner og beslægtede forbindelser som antiinfektive midler
NO20090171L (no) Substituerte aminopyrazolpyridiner og salter derav, fremgangsmate for fremstilling av slike, og farmasoytiske preparater inneholdende slike
WO2009001784A1 (ja) N-フェニル-メタナミン誘導体及びこれを含有する有害生物防除剤
NO20044633L (no) Nye alkoksypyridinderivater
HRP20120910T1 (hr) Derivati kinolina kao antibakterijska sredstva